MRNAVSNVCR• 12 Months (Normalized)
MRNA vs NVCR (Moderna Inc. vs NovoCure Limited)
Showing Closing Date Range from Sep, 15, 2025 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
MRNA Performance $143.77
+502.05%
Moderna Inc.
Normalized Baseline0.00%
NVCR Performance $16.15
+26.97%
NovoCure Limited
Normalized Baseline0.00%
Alpha Spread Margin MRNA LEADS
+475.08%
MRNA outperforming by 475.08%
MRNANVCR
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
MRNA NVCR
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | MRNA Price | MRNA Gain (%) | NVCR Price | NVCR Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $143.77 | +502.05% | $16.15 | +26.97% | +475.08% |
| Sep 14, 2026 | $146.69 | +514.28% | $16.22 | +27.52% | +486.76% |
| Sep 11, 2026 | $143.97 | +502.89% | $15.51 | +21.93% | +480.96% |
| Sep 10, 2026 | $136.62 | +472.11% | $15.35 | +20.68% | +451.43% |
| Sep 09, 2026 | $135.61 | +467.88% | $15.63 | +22.88% | +445.00% |
| Sep 08, 2026 | $140.33 | +487.65% | $16.85 | +32.47% | +455.18% |
| Sep 04, 2026 | $145.55 | +509.51% | $17.94 | +41.04% | +468.47% |
| Sep 03, 2026 | $148.87 | +523.41% | $17.64 | +38.68% | +484.73% |
| Sep 02, 2026 | $150.81 | +531.53% | $17.83 | +40.17% | +491.36% |
| Sep 01, 2026 | $154.27 | +546.02% | $17.38 | +36.64% | +509.38% |
| Aug 31, 2026 | $140.34 | +487.69% | $17.65 | +38.76% | +448.93% |
| Aug 28, 2026 | $137.99 | +477.85% | $17.82 | +40.09% | +437.76% |
| Aug 27, 2026 | $142.77 | +497.86% | $17.99 | +41.43% | +456.43% |
| Aug 26, 2026 | $149.66 | +526.72% | $17.89 | +40.64% | +486.08% |
| Aug 25, 2026 | $158.83 | +565.12% | $17.62 | +38.52% | +526.60% |
Page 1 of 17